The U-shaped relationship between admission peripheral oxygen saturation and all-cause hospital mortality in acute exacerbation of chronic obstructive pulmonary disease: a retrospective analysis using the MIMIC III database.
{"title":"The U-shaped relationship between admission peripheral oxygen saturation and all-cause hospital mortality in acute exacerbation of chronic obstructive pulmonary disease: a retrospective analysis using the MIMIC III database.","authors":"Na Meng, Chunyu Tan, Lindong Yuan, Wenjuan Xu, Pengcheng Wang, Peige Zhao","doi":"10.21037/jtd-24-1404","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic obstructive pulmonary disease (COPD) and acute exacerbation of chronic obstructive pulmonary disease (AECOPD) pose global challenges, with oxygen saturation (SpO<sub>2</sub>) levels crucial in evaluating mortality. This study explored the correlation between admission SpO<sub>2</sub> levels and all-cause hospital mortality in patients with AECOPD, assessing whether SpO<sub>2</sub> can serve as an independent risk factor for predicting in-hospital mortality in these patients.</p><p><strong>Methods: </strong>This study involved 996 AECOPD patients sourced from the Medical Information Mart for Intensive Care (MIMIC) III database (version 1.3), with 134 fatalities. Patients were categorized into a death group (n=134) and a survival group (n=862). The average admission SpO<sub>2</sub> value was recorded for all 996 AECOPD patients. Subsequently, a generalized additive model (GAM) curve was employed to examine the association between admission SpO<sub>2</sub> levels and all-cause hospital mortality. Following this, Cox regression analysis and survival analysis were conducted to further investigate the link between admission SpO<sub>2</sub> and all-cause hospital mortality.</p><p><strong>Results: </strong>The GAM curve demonstrated a non-linear, U-shaped relationship between admission SpO<sub>2</sub> and all-cause hospital mortality in AECOPD patients. The nadir of all-cause hospital mortality was associated with an SpO<sub>2</sub> of 89.5%. Notably, an SpO<sub>2</sub> of 89.5% served as the optimal cutoff for predicting all-cause hospital mortality. Cox regression analysis identified SpO<sub>2</sub> as a risk factor for all-cause hospital mortality in AECOPD patients. Patients with SpO<sub>2</sub> ≥89.5% exhibited independently lower death risk compared to those with SpO<sub>2</sub> <89.5% (hazard ratio: 0.52; 95% confidence interval: 0.37-0.74; P<0.001).</p><p><strong>Conclusions: </strong>Admission SpO<sub>2</sub> level is an independent risk factor for predicting all-cause hospital mortality in AECOPD patients and can serve as a prognostic indicator. A U-shaped relationship was observed, with an admission SpO<sub>2</sub> level of 89.5% associated with the lowest mortality, suggesting an optimal range for improved prognosis.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"17 1","pages":"60-69"},"PeriodicalIF":2.1000,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11833588/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-24-1404","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Chronic obstructive pulmonary disease (COPD) and acute exacerbation of chronic obstructive pulmonary disease (AECOPD) pose global challenges, with oxygen saturation (SpO2) levels crucial in evaluating mortality. This study explored the correlation between admission SpO2 levels and all-cause hospital mortality in patients with AECOPD, assessing whether SpO2 can serve as an independent risk factor for predicting in-hospital mortality in these patients.
Methods: This study involved 996 AECOPD patients sourced from the Medical Information Mart for Intensive Care (MIMIC) III database (version 1.3), with 134 fatalities. Patients were categorized into a death group (n=134) and a survival group (n=862). The average admission SpO2 value was recorded for all 996 AECOPD patients. Subsequently, a generalized additive model (GAM) curve was employed to examine the association between admission SpO2 levels and all-cause hospital mortality. Following this, Cox regression analysis and survival analysis were conducted to further investigate the link between admission SpO2 and all-cause hospital mortality.
Results: The GAM curve demonstrated a non-linear, U-shaped relationship between admission SpO2 and all-cause hospital mortality in AECOPD patients. The nadir of all-cause hospital mortality was associated with an SpO2 of 89.5%. Notably, an SpO2 of 89.5% served as the optimal cutoff for predicting all-cause hospital mortality. Cox regression analysis identified SpO2 as a risk factor for all-cause hospital mortality in AECOPD patients. Patients with SpO2 ≥89.5% exhibited independently lower death risk compared to those with SpO2 <89.5% (hazard ratio: 0.52; 95% confidence interval: 0.37-0.74; P<0.001).
Conclusions: Admission SpO2 level is an independent risk factor for predicting all-cause hospital mortality in AECOPD patients and can serve as a prognostic indicator. A U-shaped relationship was observed, with an admission SpO2 level of 89.5% associated with the lowest mortality, suggesting an optimal range for improved prognosis.
期刊介绍:
The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.